3[1]Ross R. Atherosclerosis-an inflammatory disease[J]. N Engl J Med, 1999, 340(2): 115-126.
4[2]Ledue TB, Rifai N. High sensitivity immunoassays for C-reactive protein: promises and pitfalls[J]. Clin Chem Lab Med, 2001, 39(11):1171-1176.
5[3]Whicher J, Rifai N, Biasucci LM. Markers of the acute phase response in cardiovascular disease: an update[J].Clin Chem Lab Med, 2001, 39(11):1054-1064.
6[4]Rifai N, Ridker PM. High-sensitivity C-reactive protein:a novel and promising marker of coronary heart disease [J]. Clin Chem, 2001,47(3):403-411.
7[5]Morley JJ, Kushner I. Serum C-reactive protein levels in disease[J]. Ann N Y Acad Sci, 1982,389:406-418.
8[8]Rothkrantz-Kos S, Schmitz MP, Bekers O, et al. Highsensitivity C-reactive protein methods examined[J]. Clin Chem, 2002,48(2): 359-362.
9[9]Ferreiros ER, Boissonnet CP, Pizarro R, et al. Independent prognostic value of elevated C-reactive protein in unstable angina [J]. Circulation, 1999,100 (19):1958-1963.
10[10]Morrow DA, Rifai N, Antman EM, et al. C-Reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy[J]. J Am Coll Cardiol ,1998; 31(7): 1460 -1465.
3Hayaishi-Okano R,Yamasaki Y,Katakami N,et al. Elevated C-reactive protein associates with early-stage carotid atheroselerosis in youngsubjects with type 1 diabetes[J]. Diabetes Care,2002,25 (8) : 1432-1438.
4Homuth V,Dechend R.Hypertension and pregnancy[J].MMW Fortschr Med,2009,151(11):41-42.
